Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure.
作者信息
Bajaj Navkaranbir S, Vaduganathan Muthiah
机构信息
University of Alabama at Birmingham, Birmingham, AL, USA.
Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA.
出版信息
Eur J Heart Fail. 2020 Sep;22(9):1638-1640. doi: 10.1002/ejhf.1856. Epub 2020 May 28.
Abstract
摘要
相似文献
1
Using antimatter to uncover what matters: metformin effects on myocardial efficiency in heart failure.利用反物质揭示关键所在：二甲双胍对心力衰竭心肌效率的影响
Eur J Heart Fail. 2020 Sep;22(9):1638-1640. doi: 10.1002/ejhf.1856. Epub 2020 May 28.
2
A randomised, double-blind, placebo-controlled trial of metformin on myocardial efficiency in insulin-resistant chronic heart failure patients without diabetes.一项随机、双盲、安慰剂对照试验，研究二甲双胍对无糖尿病的胰岛素抵抗慢性心力衰竭患者心肌效率的影响。
Eur J Heart Fail. 2020 Sep;22(9):1628-1637. doi: 10.1002/ejhf.1656. Epub 2019 Dec 21.
3
Metformin in heart failure.二甲双胍与心力衰竭
Diabetes Care. 2007 Dec;30(12):e129. doi: 10.2337/dc07-1686.
4
Metabolic Effects of Metformin in the Failing Heart.二甲双胍在心力衰竭中的代谢作用。
Int J Mol Sci. 2018 Sep 21;19(10):2869. doi: 10.3390/ijms19102869.
5
Patients with both diabetes and heart failure often treated with medications government considers unsafe.患有糖尿病和心力衰竭的患者经常使用政府认为不安全的药物进行治疗。
Rep Med Guidel Outcomes Res. 2003 Aug 8;14(15):1, 6-7.
6
Is metformin beneficial for heart failure in patients with type 2 diabetes?二甲双胍对 2 型糖尿病心力衰竭患者有益吗？
Diabetes Res Clin Pract. 2018 Feb;136:168-170. doi: 10.1016/j.diabres.2017.12.011. Epub 2017 Dec 24.
7
Metformin and heart failure: never say never again.二甲双胍与心力衰竭：永不言弃。
Expert Opin Pharmacother. 2012 Jan;13(1):1-8. doi: 10.1517/14656566.2012.638283.
8
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.二甲双胍在伴有或不伴有心力衰竭或肾功能障碍的糖尿病患者中的使用与临床结局：来自 SAVOR-TIMI 53 试验的观察。
Circulation. 2019 Sep 17;140(12):1004-1014. doi: 10.1161/CIRCULATIONAHA.119.040144. Epub 2019 Jul 31.
9
Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells.二甲双胍，不仅仅是胰岛素增敏剂，还能靶向心脏和胰腺β细胞。
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):1984-1990. doi: 10.1016/j.bbadis.2016.09.019. Epub 2016 Oct 1.
10
[Metformin. Contraindications in heart failure reconsidered].[二甲双胍。对心力衰竭禁忌证的重新审视]
Med Monatsschr Pharm. 2008 Apr;31(4):148-9.
本文引用的文献
1
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.估算射血分数降低的心力衰竭患者接受全面疾病修正药物治疗的终生获益：三项随机对照试验的比较分析。
Lancet. 2020 Jul 11;396(10244):121-128. doi: 10.1016/S0140-6736(20)30748-0. Epub 2020 May 21.
2
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.合并糖尿病与射血分数降低心衰（HFrEF）患者的当代治疗模式与临床结局：CHAMP-HF 注册研究。
JACC Heart Fail. 2020 Jun;8(6):469-480. doi: 10.1016/j.jchf.2019.12.015. Epub 2020 May 6.
3
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.达格列净对伴或不伴糖尿病的心力衰竭患者心力衰竭恶化和心血管死亡的影响。
JAMA. 2020 Apr 14;323(14):1353-1368. doi: 10.1001/jama.2020.1906.
4
A randomised, double-blind, placebo-controlled trial of metformin on myocardial efficiency in insulin-resistant chronic heart failure patients without diabetes.一项随机、双盲、安慰剂对照试验，研究二甲双胍对无糖尿病的胰岛素抵抗慢性心力衰竭患者心肌效率的影响。
Eur J Heart Fail. 2020 Sep;22(9):1628-1637. doi: 10.1002/ejhf.1656. Epub 2019 Dec 21.
5
Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week.心脏钙敏感受体激动剂、肌敏感受体激动剂和线粒体增敏剂：JACC 每周综述专题。
J Am Coll Cardiol. 2019 May 14;73(18):2345-2353. doi: 10.1016/j.jacc.2019.02.051.
6
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial.一项针对无糖尿病的冠心病患者左心室肥厚的二甲双胍随机对照试验：MET-REMODEL 试验。
Eur Heart J. 2019 Nov 1;40(41):3409-3417. doi: 10.1093/eurheartj/ehz203.
7
Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using C-acetate PET.使用 C-乙酸盐 PET 进行心肌氧化代谢、血流和外效率的可重复和可再现测量。
J Nucl Cardiol. 2018 Dec;25(6):1912-1925. doi: 10.1007/s12350-018-1206-y. Epub 2018 Feb 16.
8
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.二甲双胍对心血管疾病的影响：一项对 2 型糖尿病患者随机试验的荟萃分析。
Diabetologia. 2017 Sep;60(9):1620-1629. doi: 10.1007/s00125-017-4337-9. Epub 2017 Aug 2.
9
Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.射血分数降低的心力衰竭患者中与糖尿病前期和糖尿病相关的风险：血管紧张素受体脑啡肽酶抑制剂与血管紧张素转换酶抑制剂前瞻性比较以确定对心力衰竭试验全球死亡率和发病率影响的见解。
Circ Heart Fail. 2016 Jan;9(1). doi: 10.1161/CIRCHEARTFAILURE.115.002560.
10
The effect of metformin on insulin resistance and exercise parameters in patients with heart failure.二甲双胍对心力衰竭患者胰岛素抵抗及运动参数的影响。
Eur J Heart Fail. 2012 Nov;14(11):1303-10. doi: 10.1093/eurjhf/hfs106. Epub 2012 Jun 27.
Zotero 插件